Physician profile
Christopher Robert Manees
NPI 1528276771
$10,390.73
in general payments reported to CMS, 2019-2025
53 companies · $624 in 2025
The $624 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,433 · 2020: $1,007 · 2021: $1,894 · 2022: $1,964 · 2023: $1,732 · 2024: $737 · 2025: $624.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,093.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,092.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $1,492.64 | 2019-2020 | |
| Abbvie INC. | $1,178.08 | 2021-2025 | |
| Collegium Pharmaceutical, INC. | $873.46 | 2019-2025 | Xtampza, Belbuca |
| Medtronic, INC. | $536.88 | 2021-2025 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Amgen INC. | $435.46 | 2019-2022 | |
| Ferring Pharmaceuticals INC. | $427.31 | 2020-2024 | Euflexxa |
| Relievant Medsystems, INC. | $354.96 | 2021-2022 | |
| Nevro Corp. | $338.39 | 2019-2024 | Senza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $325.31 | 2019-2024 | Relistor |
| Tersera Therapeutics LLC | $315.77 | 2019-2023 | Prialt |
| Idorsia Pharmaceuticals US INC | $306.03 | 2022-2024 | Quviviq |
| Spr Therapeutics, INC | $305.20 | 2019-2024 | Sprint Pns System |
| Abbott Laboratories | $280.81 | 2020-2025 | Proclaim, Eterna |
| Novartis Pharmaceuticals Corporation | $242.48 | 2019-2021 | |
| Boston Scientific Corporation | $232.02 | 2019-2021 |
Show all 53 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $206.95 | 2020-2022 | |
| Protega Pharmaceutials INC | $202.05 | 2022-2025 | Roxybond |
| Biodelivery Sciences International, INC. | $191.15 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $190.50 | 2019-2022 | |
| Redhill Biopharma INC. | $187.24 | 2020-2021 | |
| Globus Medical, INC. | $169.74 | 2025 | Senza, Vyrsa V1 |
| Vertos Medical, INC. | $152.28 | 2021-2024 | Mild Device Kit |
| Biohaven Pharmaceuticals, INC. | $150.47 | 2021 | |
| Painteq LLC | $141.12 | 2023 | Painteq |
| Takeda Pharmaceuticals U.S.A., INC. | $125.54 | 2019-2020 | |
| Si-Bone, INC. | $119.35 | 2019-2021 | |
| Allergan, INC. | $87.48 | 2021-2022 | |
| Azurity Pharmaceuticals, INC. | $68.35 | 2023-2024 | Horizant, Horizant |
| Lilly USA, LLC | $62.44 | 2019-2022 | |
| Pfizer INC. | $60.82 | 2020-2025 | |
| Depuy Synthes Sales INC. | $59.80 | 2019-2022 | |
| Amneal Pharmaceuticals LLC | $56.90 | 2023 | Lyvispah |
| Almatica Pharma LLC | $47.01 | 2021 | |
| Curonix LLC | $42.96 | 2023-2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Scilex Pharmaceuticals INC. | $38.34 | 2019 | |
| Lundbeck LLC | $38.32 | 2022-2023 | Vyepti |
| Assertio Therapeutics, INC. | $28.84 | 2019 | |
| Arbor Pharmaceuticals, INC. | $28.36 | 2021 | |
| Stimwave Technologies Incorporated | $27.10 | 2021-2022 | |
| Daiichi Sankyo INC. | $24.60 | 2019 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $23.94 | 2022 | |
| Biotronik Nro, INC. | $23.48 | 2025 | Prospera |
| Masimo Corporation | $22.69 | 2023 | Patient Safetynet System |
| Bioventus LLC | $20.37 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $19.34 | 2023 | Exparel, Iovera, Zilretta |
| Ibsa Pharma INC. | $19.09 | 2021 | |
| Merck Sharp & Dohme LLC | $18.52 | 2021 | |
| Forte Bio-Pharma LLC | $18.02 | 2024 | Prolate, Nalocet |
| Biogen, INC. | $17.25 | 2021 | |
| Saluda Medical Americas, INC. | $16.63 | 2025 | Evoke |
| Valinor Pharma, LLC | $14.26 | 2024 | Movantik |
| Kowa Pharmaceuticals America, INC. | $12.64 | 2022 | |
| Virtus Pharmaceuticals LLC | $11.99 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Manees listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.